✦ LIBER ✦

DISCRIMINATION OF MEN WITH PROSTATE CANCER FROM THOSE WITH BENIGN DISEASE BY MEASUREMENTS OF HUMAN GLANDULAR KALLIKREIN 2 (HK2) IN SERUM

✍ Scribed by BECKER, CHARLOTTE; PIIRONEN, TIMO; PETTERSSON, KIM; BJöRK, THOMAS; WOJNO, KIRK J.; OESTERLING, JOSEPH E.; LILJA, HANS

Book ID: 123175358
Publisher: Lippincott Williams and Wilkins
Year: 2000
Tongue: English
Weight: 96 KB
Volume: 163
Category: Article
ISSN: 0022-5347
DOI: 10.1016/S0022-5347(05)68044-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Detection of Human Glandular Kallikrein,

Detection of Human Glandular Kallikrein, hK2, as Its Precursor Form and in Complex With Protease Inhibitors in Prostate Carcinoma Serum

✍ LANA S. GRAUER; JUDITH A. FINLAY; STEPHEN D. MIKOLAJCZYK; KELLIE D. PUSATERI; RO 📂 Article 📅 1998 🏛 American Society of Andrology 🌐 English ⚖ 910 KB

Risk assessment for biochemical recurren

Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum

✍ Thomas Steuber; Andrew J. Vickers; Alexander Haese; Charlotte Becker; Kim Petter 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 122 KB

## Abstract Most models to predict biochemical recurrence (BCR) of prostate cancer use pretreatment serum prostate‐specific antigen (PSA), clinical stage and prostate biopsy Gleason grade. We investigated whether human glandular kallikrein 2 (hK2) and free prostate‐specific antigen (fPSA) measured

128 Serum concentrations of human glandu

128 Serum concentrations of human glandular kallikrein 2 (HK2) but not free PSA, total PSA or %FPSA permit discrimination of pathologically organ-confined (OC) from non-organ confined (NOC), non-palpable (clinical stage T1C) prostate cancer

✍ A. Haese; V. Vaisanen; H. Lilja; K. Pettersson; L. Sokoll; H. Rittenhouse; H. Hu 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 214 KB

Clinical value of human glandular kallik

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater

✍ Charlotte Becker; Timo Piironen; Kim Pettersson; Jonas Hugosson; Hans Lilja 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Total and Gleason Grade 4/5 Cancer Volum

Total and Gleason Grade 4/5 Cancer Volumes are Major Contributors of Human Kallikrein 2, Whereas Free Prostate Specific Antigen is Largely Contributed by Benign Gland Volume in Serum From Patients With Prostate Cancer or Benign Prostatic Biopsies

✍ HAESE, ALEXANDER; GRAEFEN, MARKUS; STEUBER, THOMAS; BECKER, CHARLOTTE; NOLDUS, J 📂 Article 📅 2003 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 79 KB

Combination of signal intensity measurem

Combination of signal intensity measurements of lesions in the peripheral zone of prostate with MRI and serum PSA level for differentiating benign disease from prostate cancer

✍ Engelhard, K.; Hollenbach, H.-P.; Deimling, M.; Kreckel, M.; Riedl, C. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 129 KB